In the latest trading session,, 3.49 million Iovance Biotherapeutics Inc (NASDAQ:IOVA) shares changed hands as the company’s beta touched 0.81. With the company’s most recent per share price at $1.72 changing hands around $0.06 or 3.31% at last look, the market valuation stands at $572.70M. IOVA’s current price is a discount, trading about -627.33% off its 52-week high of $12.51. The share price had its 52-week low at $1.64, which suggests the last value was 4.65% up since then.
Analysts gave the Iovance Biotherapeutics Inc (IOVA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.85. If we narrow down to specifics, the data shows that 0 out of 8 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended IOVA as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight.
Iovance Biotherapeutics Inc (NASDAQ:IOVA) trade information
Instantly IOVA is in green as seen in intraday trades today. With action -11.14%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -76.82%, with the 5-day performance at -11.14% in the red. However, in the 30-day time frame, Iovance Biotherapeutics Inc (NASDAQ:IOVA) is -43.95% down.
The consensus price target for the stock as assigned by Wall Street analysts is 4, meaning bulls need an upside of 57.0% from its recent market value. According to analyst projections, IOVA’s forecast low is 2 with 6 as the target high. To hit the forecast high, the stock’s price needs a -248.84% plunge from its current level, while the stock would need to soar -16.28% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 4.17%. The 2025 estimates are for Iovance Biotherapeutics Inc earnings to increase by 10.19%, but the outlook for the next 5-year period is at 47.62% per year.
IOVA Dividends
Iovance Biotherapeutics Inc is expected to release its next quarterly earnings report in June.
PERCEPTIVE ADVISORS LLC holds the second largest percentage of outstanding shares, with 9.1052% or 25.93 million shares worth $207.98 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 8.61 shares estimated at $14.85 million under it, the former controlled 2.58% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.18% of the shares, roughly 7.28 shares worth around $12.56 million.
